Navigation Links
Unigene Announces Key Appointments as Biotechnologies Strategic Business Unit Continues to Grow in 2012
Date:2/8/2012

cer at ImClone Systems Corporation, a wholly owned subsidiary of Eli Lilly.  During his time at ImClone, Mr. Mayes helped lead the clinical development, launch and commercialization of ERBITUX® (cetuximab); was responsible for the development and oversight of the company's first corporate compliance program; and was key to Eli Lilly's acquisition and integration of ImClone.  Before ImClone, Mr. Mayes served as Senior Counsel for AstraZeneca Pharmaceuticals, LP, where he played an integral role in the provision of legal services for the successful development and commercialization of five compounds in the company's oncology portfolio.

Mr. Palmer continued, "Greg has been invaluable to Unigene's remarkable turnaround in 2011, which has now established the company as the leader in the oral delivery of peptide therapeutics.  I look forward to continuing to work closely with Greg in his expanded role as Chief Business Officer."

Dr. Pepper joins Unigene after eight years in the development organization with Novartis Pharmaceuticals where she held increased responsibilities.  She was most recently a member of the business development and licensing (BD&L) team that evaluated strategic new business opportunities, playing an important role in due diligence for early and late-phase opportunities and the successful addition of three products to Novartis' portfolio.  Additionally, Dr. Pepper led efforts to identify potential partnerships and pipeline compounds in China and other Asian markets for a development franchise.

Mr. Mayes remarked, "Jane's extensive track record of success in expanding Novartis' global product portfolio and additional accomplishments in the industry make her a welcomed addition to the Unigene leadership team.  We are extremely fortunate to have recruited an experienced, results-oriented executive such as Jane Pepper to Unigene and believe her decision to join the Company provides additional val
'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Unigene Laboratories Granted US Patent for Peptide-Based Technology for Treatment of Obesity
2. Unigene Provides 2012 Business Outlook
3. Unigene to Present at Biotech Showcase™ 2012 in San Francisco on January 9
4. Unigenes Proprietary Peptelligence™ Platform Used to Commence Cara Therapeutics Phase 1 Clinical Trial of Oral Novel Peripherally-Acting Kappa Opioid Agonist
5. Unigene Strengthens Board with the Appointment of Walgreens Executive, Thomas J. Sabatino, Jr.
6. Unigene Reports Third Quarter 2011 Financial Results
7. Unigene to Announce Third Quarter 2011 Financial Results on November 9, 2011
8. Webcast Alert: Unigene Laboratories, Inc. (UGNE) Announces Third Quarter 2010 Earnings Conference Call
9. Avanir Pharmaceuticals Announces Publication of Phase III Study Results Showing Efficacy and Safety of AVP-923 in the Treatment of Diabetic Neuropathic Pain
10. Telik Announces Presentation and Webcast at 14th Annual BIO CEO & Investor Conference
11. Cardica Announces Proposed Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2013)... May 22, 2013  Heska Corporation (NASDAQ: HSKA, "Heska" or ... products, announced today that the Company will present at the ... 2013 at the Le Parker Meridian hotel, 119 W. 56 ... . The presentation is scheduled to begin at 2:15 p.m. ... Heska Heska Corporation (NASDAQ: HSKA - ...
(Date:5/22/2013)... , May 22, 2013 /PRNewswire-iReach/ -- World markets ... with the latest trends and events, companies now ... predict where an industry is headed next, so ... (Photo: http://photos.prnewswire.com/prnh/20130522/CG19099 ) ... market research publisher GlobalData, offer decision makers and ...
(Date:5/22/2013)... Calif. , May 22, 2013   Accuray ... that its management is scheduled to present at the ... York on Thursday, June 6, 2013 at ... webcast of the presentation will be available online from ... http://www.accuray.com/investors . The webcast replay of the ...
Breaking Medicine Technology:Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 3Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 4
... TOKYO, May 22, 2007 /PRNewswire-FirstCall/ -- Sosei ... the,successful completion of a study of its ... for the treatment of cancer,breakthrough pain. , ... centre, open-label,single dose, cross-over, randomised study of ...
... /PRNewswire/ -- A three-year,follow-up subset analysis presented today ... that the CYPHER(R),Sirolimus-eluting Coronary Stent had results comparable ... and better outcomes,than bare metal stents (BMS) in ... arteries. , The CYPHER(R) Stent results in the ...
Cached Medicine Technology:Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 2Sosei Announces Successful Completion of AD 923 Pharmacokinetic,Study in the USA 3Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 2Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 3Cypher Sirolimus-Eluting Coronary Stent Had Similar Results to,Bypass Surgery and Better Outcomes Than Bare Metal Stents in,Subgroup Analysis of Diabetic Patients With Multivessel Coronary,Disease 4
(Date:5/23/2013)... (PRWEB) May 23, 2013 On May 23, ... research and advocacy, commends Salem High School senior Max Merget ... cancer. , According to a Patch.com article, Max ... with anaplastic ependymoma -- a large malignant tumor in the ... He underwent surgery but the tumor came back a year ...
(Date:5/23/2013)... To help members more easily ... pleased to announce integration of its advanced ... new upgrade automatically transfers real-time step data onto ... their company’s team standings, view progress on rewards, ... , Walkingspree also offers an integrated nutritional module ...
(Date:5/23/2013)... South Carolina (PRWEB) May 23, 2013 ... anniversary being in practice. For 25 years, Jeff ... honest legal advice with a focus on personal ... years having worked for insurance companies, he offers clients ... how insurance companies operate, which enables him better serve ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Canadian ... its Max! Healthy Vending Machines, and that's in sync ... report prepared for the Canada Organic Trade Association (COTA). ... organic food and beverages each year. This makes the ... the world. , As a Canadian leader in ...
(Date:5/23/2013)... Portland, Oregon (PRWEB) May 23, 2013 Better ... touches as it prepares to launch its one of ... Final training of management staff will be completed May 29th, ... Chris and Heather Richardson completed on site training in Portland ... the 29th to complete operational training. , "It really is ...
Breaking Medicine News(10 mins):Health News:Voices Against Brain Cancer Commends Young Man for Raising Money for Brain Cancer Despite Fighting His Own Battle 2Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 2Health News:Walkingspree Expands Device Options with Fitbit to Increase Member Engagement in Corporate Wellness Programs 3Health News:Ezell Law Firm Celebrates 25 Years in Practice 2Health News:Max! Healthy Vending Machines in Tune with Burgeoning Organic Foods Market 2Health News:Better Life Maids of Portland Oregon Prepares For a Summer of 2013 Launch 2
... Alexandria, VA - The 2011 Annual Meeting & OTO ... and Neck Surgery Foundation (AAO-HNSF), the largest meeting of ... convene September 11-14, 2011 in San Francisco, CA. ... and several hundred instruction course hours for attendees, the ...
... effective in helping patients manage their Type 2 diabetes using ... of Maryland School of Medicine researchers. The study is being ... Care . The study, one of the first to scientifically ... blood sugar control the amount of hemoglobin A1c in ...
... Reporter , FRIDAY, July 29 (HealthDay News) -- The ... it uses to approve and regulate "moderate-risk" medical devices ... a highly anticipated federal report released Friday. Instead, ... process that ensures the devices go through more rigorous ...
... College of Radiology and society of Breast Imaging, two top ... issued a statement on a controversial study published in the ... which claimed that there is no evidence that mammography served ... countries where screening has been implemented. , , The ACR ...
... -- The brains of two of four former Canadian ... associated with concussions, say researchers with the Canadian Sports ... (of the Toronto Argonauts and Hamilton Tiger-Cats) and Jay ... encephalopathy (CTE). Both players suffered repeated concussions during their ...
... July 29 (HealthDay News) -- Excluding children from discussions about ... a new study finds. Parents and medical professionals need ... them in decisions, said the researchers from Dublin, Ireland. ... to 18, at three hospitals and found that the kids ...
Cached Medicine News:Health News:World's largest meeting of ear, nose and throat doctors 2Health News:UM School of Medicine finds that mobile phone technology helps patients manage diabetes 2Health News:Report Urges New Review System for Medical Devices 2Health News:Report Urges New Review System for Medical Devices 3Health News:Concussion Project Finds Disease in Two Autopsied Brains 2Health News:Study Finds Kids Want More Info About Their Hospital Care 2
... Codman Sofwire Cable System, ... fixation including sublaminar interspinous ... facial surgery, sternotomy closure. ... and a complete set ...
Demineralized bone matrix dispensed in a jar. Fibers will be free of foreign matter. Glycerol 70-88% by weight. Calcium content less than 8%....
... Inductive demineralized bone matrix ... and cancellous chips will be ... bone matrix particle size is ... chip particle size is 1 ...
Demineralized Freeze-dried Bone Allograft (DFDBA) processed from cortical bone. Demineralized cortical powder is free of all soft tissue....
Medicine Products: